BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 29125367)

  • 1. Recent advances in the management of pancreatic adenocarcinoma.
    Karakas Y; Lacin S; Yalcin S
    Expert Rev Anticancer Ther; 2018 Jan; 18(1):51-62. PubMed ID: 29125367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current standards and new innovative approaches for treatment of pancreatic cancer.
    Conroy T; Bachet JB; Ayav A; Huguet F; Lambert A; Caramella C; Maréchal R; Van Laethem JL; Ducreux M
    Eur J Cancer; 2016 Apr; 57():10-22. PubMed ID: 26851397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of pancreatic adenocarcinoma].
    Böhmig M; Wiedenmann B; Rosewicz S
    Med Klin (Munich); 1999 Nov; 94(11):614-25. PubMed ID: 10603733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
    Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
    Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of localized, locally advanced and metastatic pancreatic adenocarcinoma].
    Delpero JR; Turrini O; Raoul JL
    Rev Prat; 2015 Mar; 65(3):382-9. PubMed ID: 26016202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic cancer.
    Cohen SJ; Pinover WH; Watson JC; Meropol NJ
    Curr Treat Options Oncol; 2000 Dec; 1(5):375-86. PubMed ID: 12057145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage III pancreatic cancer and the role of irreversible electroporation.
    Al Efishat M; Wolfgang CL; Weiss MJ
    BMJ; 2015 Mar; 350():h521. PubMed ID: 25787829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant therapy in pancreatic cancer].
    Ji JF; Li ZY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Oct; 27(5):644-7. PubMed ID: 16274051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant therapy of pancreatic cancer.
    Hilbig A; Oettle H
    Expert Rev Anticancer Ther; 2010 Apr; 10(4):485-91. PubMed ID: 20397913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New directions in systemic therapy of pancreatic cancer.
    Rosemurgy AS; Serafini FM
    Cancer Control; 2000; 7(5):437-51. PubMed ID: 11000613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic cancer: current and future treatment strategies.
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Aug; 35(5):431-6. PubMed ID: 19328630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene therapy for pancreatic cancer--current and prospective strategies.
    Halloran CM; Ghaneh P; Neoptolemos JP; Costello E
    Surg Oncol; 2000 Dec; 9(4):181-91. PubMed ID: 11476989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy for resectable pancreatic adenocarcinoma: review of the current treatment approaches and future directions.
    Antoniou G; Kountourakis P; Papadimitriou K; Vassiliou V; Papamichael D
    Cancer Treat Rev; 2014 Feb; 40(1):78-85. PubMed ID: 23810287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
    Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Pancreatic Adenocarcinoma in Elderly Patients over 75 Years of Age: A Retrospective Series of 129 Patients.
    Oziel-Taieb S; Faure M; Gilabert M; Autret A; Turrini O; Moureau-Zabotto L; Giovannini M; Rousseau F; Raoul JL
    J Gastrointest Cancer; 2016 Mar; 47(1):15-9. PubMed ID: 26545612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Locally advanced adenocarcinoma of the pancreas: current therapeutic modalities].
    Lombard-Bohas C; Mornex F; Saurin JC
    Cancer Radiother; 1997; 1(5):547-54. PubMed ID: 9587388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pancreatic carcinoma].
    Böhmig M; Rosewicz S
    Z Gastroenterol; 2004 Mar; 42(3):261-8. PubMed ID: 15022114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic adenocarcinoma: Clinical Practice Guidelines in Oncology.
    Tempero MA; Behrman S; Ben-Josef E; Benson AB; Cameron JL; Casper ES; Hoffman JP; Karl RC; Kim P; Koh WJ; Kuvshinoff BW; Melvin WS; Muscarella P; Sasson AR; Shibata S; Shrieve DC; Talamonti MS; Tyler DS; Vickers SM; Warren RS; Willett C; Wolff RA;
    J Natl Compr Canc Netw; 2005 Sep; 3(5):598-626. PubMed ID: 16194453
    [No Abstract]   [Full Text] [Related]  

  • 19. [Best supportive care of pancreatic carcinoma].
    Schoppmeyer K; Mössner J
    Internist (Berl); 2004 Jul; 45(7):769-76. PubMed ID: 15160243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current challenges in optimizing systemic therapy for patients with pancreatic cancer: expert perspectives from the Australasian Gastrointestinal Trials Group (AGITG) with invited international faculty.
    Segelov E; Lordick F; Goldstein D; Chantrill LA; Croagh D; Lawrence B; Arnold D; Chau I; Obermannova R; Price TJ
    Expert Rev Anticancer Ther; 2017 Oct; 17(10):951-964. PubMed ID: 28817982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.